A Study of Brenipatide in Participants With Major Depressive Disorder
Eligible age
18–75 yrs
Accepts
All genders
Locations
11 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study evaluates the safety and efficacy of brenipatide (LY3537031) as an add on therapy in participants with major depression who still have symptoms while taking a stable dose of standard of care anti-depressant medicine. The study will last approximately 5 months.
Sponsor: Eli Lilly and Company
You may qualify if…
- ✓ Have a diagnosis of Major Depressive Disorder (MDD) and are in a current major depressive episode, without psychotic features
- ✓ Are on a stable antidepressant monotherapy regimen for the current major depressive episode
- ✓ Are a partial responder to the current antidepressant monotherapy regimen
- ✓ Are reliable and willing to make themselves available for the duration of the study and attend required study visits, and are willing and able to follow study procedures as required, such as:
- ✓ self-inject study intervention
- ✓ store and use the provided blinded study intervention, as directed
- ✓ maintain electronic and paper study diaries, as applicable, and
- ✓ complete the required questionnaires
You may not qualify if…
- ✕ Have a lifetime history or current diagnosis of the following:
- ✕ schizophrenia or other psychotic disorder
- ✕ bipolar disorder
- ✕ borderline personality disorder
- ✕ other personality disorders that would interfere with compliance with the study protocol
- ✕ neurocognitive disorders or intellectual disability, or
- ✕ any eating disorder
- ✕ Have type 1 diabetes mellitus, or a history of
Where it's recruiting
Chino · Fountain Valley · Montclair · Oceanside …
Hollywood · Jacksonville · Orlando · Plant City …
Atlanta · Decatur · Savannah
Boston · Watertown
Las Vegas
Marlton · Toms River
Cedarhurst · Mount Kisco · New York · Staten Island
Allentown · Philadelphia
Dallas · DeSoto · Houston
Fairfax
Bellevue
Source: ClinicalTrials.gov · NCT07928245 · last updated 2026-11-20